Back to News
Market Impact: 0.2
State Street SPDR S&P Biotech ETF Experiences Big Outflow
Source: Nasdaq
Healthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
State Street SPDR S&P Biotech ETF (XBI) recorded approximately $184.3 million in weekly outflows, reducing shares outstanding by 1.7%. The redemption activity signals modestly weaker investor positioning toward the biotech sector, though the reported flow is unlikely to have broad market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
STT0.00
More News
- Investors brace for possible rate hike at uncertain Fed meeting
- IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Wall Street thought the Powell hike was over. Now Kevin Warsh has his ‘back against the wall’
- Analysis: Hot CPI puts Kevin Warsh’s Fed credibility on the line before rate decision